viewAnteris Technologies Ltd

Admedus Ltd's new appointments strengthen revenue generation focus


Specialist healthcare company Admedus Ltd (ASX:AHZ), continues to advance the restructure of its global operations.

Admedus has also achieved on target sales growth, with first quarter revenue being the strongest in the history of the company.

The company has appointed Michael Walker as regional vice president, Europe and Eileen Petersen as field force optimisation manager.

Both bring global experience to Admedus and will strengthen the company’s sales focus and capabilities.

Wayne Paterson, chairman and CEO, commented: "We have turned the ship and we are now heading in the right direction in terms of sales growth and reducing expenses.

"The new appointments strengthen our global marketing capabilities, which will benefit our ADAPT® technology portfolio."

Admedus has commercialised its innovative tissue engineering technology for regenerative medicine in four continents.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Anteris Technologies Ltd

Price: 4.07 AUD

Market: ASX
Market Cap: $24.05 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the...


Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read